VEGFA and neoplasm: In vivo studies were conducted with H460 cells to confirm the apoptotic and antiangiogenic effects of PROS, which revealed significantly decreased tumor growth was mediated via the activation of cleaved caspase 3 and downregulation of VEGF and STAT3 expression as compared to the control group.